benign strictures after hepaticojejunostomy benign strictures
Conditions
Interventions
After dilating the anastomotic stenosis with a balloon smaller than 8 mm, FC-SEMS (M-Intraductal, 8 mm x 30 mm) is placed in the left and right bile ducts if both hepatic lobes are present, in the ant
Metallic stent FC-SEMS)
Sponsors
Okusaka Takushi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) no tumor is found at the anastomotic site by imaging, no hepatic duct stone is found, and benign bile duct jejunal anastomotic stricture is suspected. 2) Cholangitis is consistent. 3) The patient satisfies the conditions for the procedure of the saddle-cross technique. 4) No bleeding tendency. 5) Performance status (ECOG): 0, 1, 2. 6) Age > 20 years. 7) Patient's free written consent to participate in the study has been obtained.
Exclusion criteria
Exclusion criteria: 1) The physician deems the patient ineligible for enrollment in this study. 2) The patient is severely ill in the severity classification of acute cholangitis (diagnostic criteria and severity follow Tokyo Guidelines 2018 [21]). 3) Intrahepatic stones evident on CT or MRI (Patients with bile duct stones on CT or MRI will be considered for enrollment in the study after stone removal treatment).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Long-term restenosis-free rate (at 12 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) rate of adverse events, 2) procedural success rate of endoscopic bile duct jejunal anastomosis dilatation with two FC-SEMS, 3) clinical success rate of endoscopic bile duct jejunal anastomosis dilatation with two FC-SEMS, 4) procedure time, 5) time to stenosis recurrence, 6) rate of spontaneous stent deviation, 7) time to stenosis recurrence in cases of spontaneous stent deviation. | — |
Contacts
Public ContactSusumu Hijioka
National cancer center hospital, Japan
Outcome results
None listed